Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults
Authors
Keywords
Vaccination and immunization, Antibodies, Enzyme-linked immunoassays, Vaccines, Booster doses, Malaria, Adverse events, Antibody response
Journal
PLoS One
Volume 11, Issue 10, Pages e0163144
Publisher
Public Library of Science (PLoS)
Online
2016-10-18
DOI
10.1371/journal.pone.0163144
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children
- (2016) Ally Olotu et al. NEW ENGLAND JOURNAL OF MEDICINE
- The March Toward Malaria Vaccines
- (2015) Stephen L. Hoffman et al. AMERICAN JOURNAL OF PREVENTIVE MEDICINE
- Reversible Conformational Change in the Plasmodium falciparum Circumsporozoite Protein Masks Its Adhesion Domains
- (2015) Raul Herrera et al. INFECTION AND IMMUNITY
- Development of a transmission-blocking malaria vaccine: Progress, challenges, and the path forward
- (2014) Julia K. Nunes et al. VACCINE
- Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites
- (2014) PLOS MEDICINE
- Malaria vaccines: past, present and future
- (2013) L. von Seidlein et al. ARCHIVES OF DISEASE IN CHILDHOOD
- Qualification of Standard Membrane-Feeding Assay with Plasmodium falciparum Malaria and Potential Improvements for Future Assays
- (2013) Kazutoyo Miura et al. PLoS One
- Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine
- (2013) R. A. Seder et al. SCIENCE
- Development of a Pfs25-EPA malaria transmission blocking vaccine as a chemically conjugated nanoparticle
- (2013) Richard L. Shimp et al. VACCINE
- Vaccination and herd immunity
- (2012) Harunor Rashid et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Measuring the blockade of malaria transmission – An analysis of the Standard Membrane Feeding Assay
- (2012) Thomas S. Churcher et al. INTERNATIONAL JOURNAL FOR PARASITOLOGY
- Phase 1 Study in Malaria Naïve Adults of BSAM2/Alhydrogel®+CPG 7909, a Blood Stage Vaccine against P. falciparum Malaria
- (2012) Ruth D. Ellis et al. PLoS One
- The Vi Conjugate Typhoid Vaccine Is Safe, Elicits Protective Levels of IgG Anti-Vi, and Is Compatible with Routine Infant Vaccines
- (2011) Vu Dinh Thiem et al. Clinical and Vaccine Immunology
- The IC50 of anti-Pfs25 antibody in membrane-feeding assay varies among species
- (2010) Lediya Cheru et al. VACCINE
- Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1–4-year-old Israeli children
- (2010) Justen H. Passwell et al. VACCINE
- Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51
- (2008) Yimin Wu et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started